Skip to main content

Better Therapeutics, Inc. (BTTX)

NASDAQ: BTTX · IEX Real-Time Price · USD
6.55
-0.09 (-1.36%)
At close: Dec 3, 2021 4:00 PM
6.30
-0.25 (-3.82%)
After-hours:Dec 3, 2021 6:05 PM EST
Market Cap154.58M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out23.60M
EPS (ttm)-5.65
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume255,669
Open6.66
Previous Close6.64
Day's Range6.24 - 6.71
52-Week Range6.01 - 29.40
Beta0.03
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BTTX

Better Therapeutics, Inc. develops prescription digital therapeutics. It is developing Nutritional Cognitive Behavioral Therapy (Nutritional CBT), a behavioral therapy for patients with type 2 diabetes and other cardiometabolic diseases. Its development pipeline products include BT?001 for type2 diabetes; BT?002 for Type 2 diabetes with hypertension; BT?003 for hypertension; and BT?004 for hyperlipidemia. The company was incorporated in 2015 and is based in San Francisco, California.

IndustryBiotechnology
Founded2015
Employees40
Stock ExchangeNASDAQ
Ticker SymbolBTTX
Full Company Profile

Financial Performance

In 2020, BTTX's revenue was $8,000, a decrease of -55.56% compared to the previous year's $18,000. Losses were -$6.39 million, 10.4% more than in 2019.

Financial Statements

News

Better Therapeutics Appoints Deepti Sodhi Jaggi, PharmD, as Chief Strategy Officer

SAN FRANCISCO--(BUSINESS WIRE)---- $BTTX--Better Therapeutics, Inc. (“Better Therapeutics”; NASDAQ: BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address ...

4 days ago - Business Wire

Better Therapeutics Completes Enrollment of Pivotal Trial for BT-001, a Prescription Digital Therapeutic for Type 2 D...

SAN FRANCISCO--(BUSINESS WIRE)---- $BTTX--Better Therapeutics, Inc. (“Better Therapeutics”; NASDAQ: BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address ...

2 weeks ago - Business Wire

Better Therapeutics Appoints Major General Elder Granger, M.D., U.S. Army (retired) to its Board of Directors

SAN FRANCISCO--(BUSINESS WIRE)---- $BTTX--Better Therapeutics, Inc. (“Better Therapeutics”; NASDAQ: BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address ...

3 weeks ago - Business Wire

7 New Stocks That Can Provide Long-Term Gains After Their IPOs

With 2021 proving to be the year of compelling IPOs, here are some new stocks to consider if you're feeling in a risk-on mood. The post 7 New Stocks That Can Provide Long-Term Gains After Their IPOs app...

4 weeks ago - InvestorPlace

Better Therapeutics Appoints Thiago Licias de Oliveira as Its Chief People Officer

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”; NASDAQ: BTTX), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root c...

1 month ago - Business Wire

Mass General Brigham Joins Better Therapeutics in Real World Evidence Study Collaboration

SAN FRANCISCO--(BUSINESS WIRE)---- $BTTX--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root cause...

1 month ago - Business Wire

Better Therapeutics SPAC Merger: 8 Things for BTTX Stock Investors to Know

Better Therapeutics (BTTX) stock is surging higher on Monday after completing its SPAC merger with Mountain Crest Acquisition Corp II. The post Better Therapeutics SPAC Merger: 8 Things for BTTX Stock I...

Other symbols:AURC
1 month ago - InvestorPlace

Better Therapeutics Closes Business Combination and Debuts on Nasdaq

SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)---- $BTTX--Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of ca...

1 month ago - Business Wire

Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.

Trading Under New Ticker Symbol “BTTX” Expected to Begin Friday, October 29, 2021 Trading Under New Ticker Symbol “BTTX” Expected to Begin Friday, October 29, 2021

1 month ago - GlobeNewsWire

Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and S...

NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCAD, “Mountain Crest II”), a publicly-traded special purpose acquisition company and Better Th...

1 month ago - GlobeNewsWire

Better Therapeutics to Participate in Lake Street's 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of car...

2 months ago - Business Wire

Better Therapeutics Highlights Recent Progress and Updates Outlook Through 2022

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of car...

2 months ago - Business Wire

Better Therapeutics Expands Real-World Evidence Study Initiative With Addition of Catalyst Health Network

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardi...

3 months ago - Business Wire

Better Therapeutics, Inc. to Present at the Canaccord Genuity's 41st Annual Growth Conference

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

4 months ago - Business Wire

Better Therapeutics and Colorado Prevention Center Clinical Research Launch Real-World Evidence Study of Prescription...

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

4 months ago - Business Wire

Better Therapeutics to Participate in Cowen 6th Annual FutureHealth Conference

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

5 months ago - Business Wire

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MCAD, CAHC, ROT, MUDS, LATN; Shareholders are Encouraged to Contac...

NEW YORK, April 29, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Mountain Crest Acquisition Corp. II (NASDAQ: MCAD)  c...

Other symbols:MUDS
7 months ago - PRNewsWire

Better Therapeutics Commences Pivotal Study of Prescription Digital Therapeutic for the Treatment of Type 2 Diabetes

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc., (“Better Therapeutics”) a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

7 months ago - Business Wire

Better Therapeutics Launches Real World Evidence Study of Prescription Digital Therapeutic for Type 2 Diabetes

SAN FRANCISCO--(BUSINESS WIRE)--Better Therapeutics, Inc. (“Better Therapeutics”), a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardi...

7 months ago - Business Wire

Better Therapeutics To Go Public Via Mountain Crest SPAC Deal

Better Therapeutics Inc, a company developing prescription-only smartphone-based treatments for Type 2 diabetes and high blood pressure, has agreed to go public through a merger with a blank-check compa...

7 months ago - Benzinga

Better Therapeutics to Become Publicly Traded Prescription Digital Therapeutics Company via Merger with Mountain Cres...

SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)--Better Therapeutics, Inc. a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic dis...

7 months ago - Business Wire

Mountain Crest Acquisition Corp. II Announces that Common Stock and Rights to Commence Separate Trading on or about M...

New York, N.Y., March 15, 2021 (GLOBE NEWSWIRE) -- March 15, 2021 Mountain Crest Acquisition Corp. II (the “Company”) (NASDAQ: MCADU), a blank check company formed for the purpose of entering into a mer...

8 months ago - GlobeNewsWire

Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its...

New York, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCADU, the “Company”) announced today that the underwriters in its initial public offering, pursuant to the terms...

10 months ago - GlobeNewsWire

Mountain Crest Acquisition Corp. II Announces Closing of $50 Million Initial Public Offering

New York, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCADU, the “Company”) announced today that it closed its initial public offering of 5,000,000 units at $10.00 per...

10 months ago - GlobeNewsWire

Mountain Crest Acquisition Corp. II Announces Pricing of $50 Million Initial Public Offering

New York, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ: MCADU, the “Company”) announced today that it priced its initial public offering of 5,000,000 units at $10.00 per...

10 months ago - GlobeNewsWire